₹12–18 Crore Phase 1 investment. ₹11–16 Crore Year 1 revenue. 61% hardware margins. 17.9% CAGR market. Backed by M.S. Ramaiah Group's 60+ year healthcare legacy and Google AI Health partnership.
While competitors like Practo ($500M valuation), Tata 1mg (₹14,800 Cr valuation), and Mfine / Clinics on Cloud ($105M raised) have spent massive venture capital to build fragmented platforms, MSR Health AI achieves similar market scalability with an initial Phase 1 CapEx of just ₹12–18 Cr. This unparalleled capital efficiency is unlocked by the existing MSR hospital ecosystem (1,900+ beds) and Lattice's prior ₹6.5 Cr R&D investment.
📊 View Deep Smart CapEx AnalysisEvery MSR-H650 kiosk sold generates 53-61% gross margin at ₹15L–₹35L price points. Plus ₹1.56L annual recurring revenue per deployed unit.
With 1,000 deployed kiosks:
₹15.6 Crore / yearRecurring — grows every year as fleet expands
MSR Group owns the brand, manufacturing, distribution, and hospital ecosystem. Lattice Consulting provides the AI platform, cloud infrastructure, and digital marketing engine.
MSR (85%): Brand ownership, manufacturing, distribution, regulatory, government relations, hospital integration
Lattice (15%): AI platform, cloud, mobile app, ABDM, marketing, SaaS
Over the last 2 years (2024–2026), Lattice Consulting Worldwide has invested ₹6.5 Crore in building the complete AI platform, LLM integration, and prototype product — all production-ready before a single unit is sold.
Low-cost entry → rapid scaling → full Make in India. Total ₹25-44 Crore across 5 years to build a ₹900 Crore annual revenue business.
Import CKD kits from Huasheng (China), assemble in Bengaluru, validate at Ramaiah institutions
60% Indian content. Expand to KIADB facility. Government procurement begins.
80-85% Indian content. R&D at MSRIT. PLI scheme (5% incentive). Pan-India distribution.
From ₹15.4 Crore (Year 1) to ₹900 Crore (Year 5). Investment fully recovered by Year 1. Self-funded growth from Year 4.
| Year | Units Sold | Hardware Revenue | AMC + SaaS | Other Recurring | Total Revenue | Net Profit |
|---|---|---|---|---|---|---|
| Year 1 | 80–120 | ₹15 Cr | ₹0.3 Cr | ₹0.1 Cr | ₹15.4 Cr | ₹4–6 Cr |
| Year 2 | 400–600 | ₹65 Cr | ₹2.5 Cr | ₹0.5 Cr | ₹68 Cr | ₹14–20 Cr |
| Year 3 | 1,500–2,000 | ₹215 Cr | ₹12 Cr | ₹3 Cr | ₹230 Cr | ₹48–70 Cr |
| Year 4 | 4,000–6,000 | ₹450 Cr | ₹32 Cr | ₹8 Cr | ₹490 Cr | ₹95–140 Cr |
| Year 5 | 8,000–12,000 | ₹820 Cr | ₹65 Cr | ₹15 Cr | ₹900 Cr | ₹190–270 Cr |
Year 5 Revenue Share (85% of ₹900 Cr)
Year 5 Revenue Share (15% of ₹900 Cr)
Lean operations model. Phase 1 monthly burn: ₹12-15 Lakhs. Breakeven at just 8-10 kiosk sales per month.
With monthly burn of ₹12L and gross margin of ₹7.68L per government kiosk (₹10.68L per private sale):
A pharmacy deploying MSR-H650:
India's health kiosk market is the fastest growing in Asia at 17.9% CAGR. MSR Health AI is positioned to capture 5-8% market share by Year 5.
Fastest growing health kiosk market in Asia
India's broader MedTech market is ₹1.42 lakh Crore (USD 17B) today, growing to ₹4.17 lakh Crore (USD 50B) by 2030. 70-80% is currently imported — massive Make in India opportunity.
are from preventable Non-Communicable Diseases (NCDs)
M.S. Ramaiah Group — 19 institutions, 1,900+ beds, JCI Gold. No startup can replicate this trust.
MedGemma + AMIE + PH-LLM. Only health kiosk company with official Google partnership.
2 years of AI, LLM & prototype development already invested — AI engine, cloud, apps, ABDM all production-ready.
Direct access to Karnataka CM office, state departments, and central NHM tenders through Ramaiah network.
Hardware + SaaS + AMC + Telemedicine + E-Pharmacy + Data + Franchise. Not just a one-time hardware sale.